Approximately 50% of pharmaceuticals today are derived from or inspired by natural products, including compounds from plants, microorganisms, and marine organisms. This number has seen significant decline in recent decades. Natural product drug development is limited by their structural complexity, which introduces manufacturing challenges.

Recent advancements in high-throughput screening (HTS), genomics, and bioprocessing have dramatically reduced these barriers, unlocking a vast library of compounds available in nature. Natural products offer unique chemical diversity that often surpasses synthetic drugs, providing innovative solutions for complex diseases. These compounds typically exhibit lower toxicity, as many are naturally designed to function within biological systems, and they have proven especially effective against "undruggable" targets like protein-protein interactions and allosteric sites, where synthetic molecules frequently fall short.

At the intersection of tradition and innovation, we are dedicated to harnessing these advancements to create safer, more effective therapies inspired by the natural world.